Josefa Chuh
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
- Radiopharmaceutical Chemistry and Applications
- Oncology top 10%
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
Papers in
- Oncology 6
- HER2/EGFR in Cancer Research 4
- CAR-T cell therapy research 3
-
- Monoclonal and Polyclonal Antibodies Research 6
- Co-authors
- Katherine R. Kozak (9 shared papers)Kedan Lin (3 shared papers)Crystal Zhang (3 shared papers)Andrew G. Polson (2 shared papers)Neelima Koppada (1 shared paper)Herman Gill (1 shared paper)Surinder Kaur (1 shared paper)Ola M. Saad (1 shared paper)
- Journals
- Cancer Research (3 papers)Bioconjugate Chemistry (2 papers)Molecular Cancer Therapeutics (2 papers)mAbs (1 paper)Lab on a Chip (1 paper)
- Partner nations
- United StatesFranceSouth Korea
In The Last Decade
Josefa Chuh
9 papers receiving 386 citations
Peers
Comparison fields: 5 of 43
- Radiology, Nuclear Medicine and Imaging 230
- Oncology 254
- Immunology and Allergy 25
- Immunology 52
- Biotechnology 20
Countries citing papers authored by Josefa Chuh
This map shows the geographic impact of Josefa Chuh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josefa Chuh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josefa Chuh more than expected).
Fields of papers citing papers by Josefa Chuh
This network shows the impact of papers produced by Josefa Chuh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josefa Chuh. The network helps show where Josefa Chuh may publish in the future.
Co-authors
The 25 scholars most cited alongside Josefa Chuh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 157 | |
| 2 | 2017 | 102 | |
| 3 | 2014 | 55 | |
| 4 | 2009 | 44 | |
| 5 | 2013 | 24 | |
| 6 | 2013 | 16 | |
| 7 | 2020 | 9 | |
| 8 | 2014 | 1 | |
| 9 | 2014 | 1 |
About Josefa Chuh
Josefa Chuh is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine, Biotechnology and Molecular Biology, having authored 9 papers that have together received 409 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (6 papers), HER2/EGFR in Cancer Research (4 papers), CAR-T cell therapy research (3 papers), Cancer Research and Treatments (2 papers), Occupational and environmental lung diseases (2 papers), Lymphoma Diagnosis and Treatment (1 paper), Microtubule and mitosis dynamics (1 paper) and Chemotherapy-induced cardiotoxicity and mitigation (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (230 citations), Oncology (254 citations), Immunology and Allergy (25 citations), Immunology (52 citations) and Biotechnology (20 citations). Josefa Chuh has collaborated with scholars based in United States, France and South Korea. Frequent co-authors include Katherine R. Kozak, Kedan Lin, Crystal Zhang, Andrew G. Polson, Neelima Koppada, Herman Gill, Surinder Kaur, Ola M. Saad, Ben‐Quan Shen and Daniela Bumbaca. Their work appears in journals such as Cancer Research, Bioconjugate Chemistry, Molecular Cancer Therapeutics, mAbs and Lab on a Chip.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.